Melodiol Global Health (COPHF) Stock Price, News & Analysis

Company Overview

Melodiol Global Health Inc is a clinical-stage life sciences company focused on the research, development and commercialization of novel therapeutic products derived from cannabinoids and psychedelic compounds. The company’s mission is to advance safe, evidence-based medicine that addresses areas of unmet medical need in mental health, neurology and pain management by harnessing the therapeutic potential of targeted botanical extracts and synthetic analogues.

Melodiol’s product pipeline encompasses proprietary formulations designed to improve bioavailability, optimize dosing and enhance patient compliance. Key programs include oral and sublingual delivery systems for cannabidiol (CBD) and novel psychedelic derivatives for treatment-resistant depression and post-traumatic stress disorder (PTSD). The company’s research efforts are supported by laboratory facilities and partnerships with academic institutions, where preclinical and early-stage clinical trials are conducted to validate safety and efficacy profiles.

Headquartered in Canada, Melodiol Global Health is actively pursuing regulatory approvals and commercialization pathways in North America and select international markets. The company maintains strategic alliances with contract research organizations, extraction specialists and distribution partners to streamline manufacturing and market access. Melodiol’s leadership team brings experience in pharmaceutical development, regulatory affairs and botanical product commercialization, positioning the company to address evolving healthcare challenges through scientifically grounded plant-based innovations.

Key Stats

• Today's Range: $0.12 to $0.12
• 50-Day Range: $0.12 to $0.12
• 52-Week Range: $0.00 to $9.47
• Volume: N/A
• Average Volume: 451 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:COPHF
• CIK: N/A
• Web: www.cresopharma.com
• Phone: 61-8-9389-3180
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A